Serum adiponectin in young adults—interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study

This publication has 24 references indexed in Scilit:

• Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
  Diabetologia, 2003
• The Peroxisome Proliferator-Activated Receptor-γ2 Pro12Ala Polymorphism
  Diabetes, 2002
• Plasma Adiponectin Concentration Is Associated With Skeletal Muscle Insulin Receptor Tyrosine Phosphorylation, and Low Plasma Concentration Precedes a Decrease in Whole-Body Insulin Sensitivity in Humans
  Diabetes, 2002
• Synthetic Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Increases Plasma Levels of Adiponectin in Type 2 Diabetic Patients
  Diabetes Care, 2002
• PPARγ Ligands Increase Expression and Plasma Concentrations of Adiponectin, an Adipose-Derived Protein
  Diabetes, 2001
• The Genetic Basis of Plasma Variation in Adiponectin, a Global Endophenotype for Obesity and the Metabolic Syndrome
  Journal of Clinical Endocrinology & Metabolism, 2001
• The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
  Nature Medicine, 2001
• Circulating Concentrations of the Adipocyte Protein Adiponectin Are Decreased in Parallel With Reduced Insulin Sensitivity During the Progression to Type 2 Diabetes in Rhesus Monkeys
  Diabetes, 2001
• Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
  Biochemical and Biophysical Research Communications, 1999
• The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
  Archives of internal medicine (1960), 1997